TELOMERASE ASSOCIATED FACTORS AND THEIR ROLES IN CANCER PROGRESSION

端粒酶相关因子及其在癌症进展中的作用

• 批准号: 7601841
• 负责人: ELIZABETH H BLACKBURN
• 金额: $ 0.01万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-30 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7601841
• 关键词: Affinity Chromatography; Cancer Cell Growth; Cancer cell line; Cell Proliferation; Cells; Complex; Computer Retrieval of Information on Scientific Projects Database; DNA Microarray Chip; DNA Microarray format; Data; Disruption; Double-Stranded RNA; Funding; Gene Expression; Grant; Growth; HeLa S3; Human; Induction of Apoptosis; Institution; Interferons; Malignant Neoplasms; Mass Spectrum Analysis; Microarray Analysis; Proteins; Protocols documentation; Research; Research Personnel; Resources; Ribonucleoproteins; Role; Small Interfering RNA; Source; Structure; Telomerase; Telomerase RNA Component; Telomerase inhibition; Telomere Length Maintenance; Telomere Shortening; United States National Institutes of Health; cancer cell; cell growth; novel; response; telomere; tumor progression

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Cancer cells commonly upregulate the ribonucleoprotein telomerase. Inhibition of telomerase has previously been predicted to slow cancer growth, but only after a sufficient period elapses for telomere shortening to occur. Recently, we have inhibited cancer cell growth specifically by inhibiting telomerase function through an siRNA targeting the template region of wild-type telomerase RNA. Expression of such siRNA in cancer cells resulted in dramatic reduction of telomerase activity, rapid inhibition of cell growth and induction of apoptosis. Unexpectedly, those potent cellular effects were not apparently induced by the disruption of telomere structures, suggesting that inhibition of telomerase by siRNA may inhibit a function of telomerase in cancer cells other than telomere length maintenance. DNA microarray analysis in these cells indicates rapid changes in growth-related gene expression that is independent of interferon response triggered by double stranded RNA. These data suggested that telomerase may be essential for cancer cell proliferation in addition to telomere length maintenance. Therefore, a main focus of our research is to further understand the underlying mechanisms by which telomerase regulates cell proliferation through identification of novel telomerase associated factors. Biochemistal purification of telomerase complexes from the human cancer cell line Hela S3 was achieved using Tandem affinity purification (TAP) protocol. Proteins associated specifically with telomerase were isolated for identification by Mass Spectrometry.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 癌细胞通常上调核糖核蛋白端粒酶。以前曾预测抑制端粒酶可以减缓癌症的生长，但只有在端粒缩短发生足够长的时间之后。最近，我们通过靶向野生型端粒酶RNA的模板区域的siRNA抑制端粒酶功能来特异性地抑制癌细胞生长。这种siRNA在癌细胞中的表达导致端粒酶活性的显著降低、细胞生长的快速抑制和凋亡的诱导。出乎意料的是，这些有效的细胞效应并没有明显地被端粒结构的破坏所诱导，这表明通过siRNA抑制端粒酶可能抑制癌细胞中端粒酶的功能而不是端粒长度维持。在这些细胞中的DNA微阵列分析表明，生长相关基因表达的快速变化是独立的干扰素反应触发的双链RNA。这些数据表明，端粒酶可能是必不可少的癌细胞增殖除了端粒长度的维持。因此，我们的研究重点是通过鉴定新的端粒酶相关因子来进一步了解端粒酶调节细胞增殖的潜在机制。采用串联亲和纯化（TAP）法对人癌细胞系Hela S3中端粒酶复合物进行了生物化学纯化。分离与端粒酶特异性相关的蛋白质用于通过质谱法鉴定。